Nevisense is now commercially available in Belgium, Great Britain, Germany, Australia, Austria, Switzerland, Nordic markets, and the US. For more information regarding sales and ordering in these markets either e-mail us at order@scibase.com or contact one of our representatives below:

GERMANY

Dr. Emanuel von Kienlin, Managing Director (based in Munich, Germany) E-mail: emanuel.vonkienlin@scibase.com Phone: +49-172-823 3386
Katja Hardies Sales West Germany (based in Cologne, Germany) E-mail: katja.hardies@scibase.com Phone: +49-176-187 90950
Ralf Anton Sales Agent North/Central/East Germany (based in Freigericht, Germany)  E-mail: ralf.anton@scibase.com Phone: +49-170-5705423
Bernd Schmiedl Sales Agent South/West Germany (based in Seligenstadt, Germany)  E-mail: bernd.schmiedl@scibase.com Phone: +49-152-044 77306
For the German site, please click here.

AUSTRALIA

Australian Dermatology Equipment Tel: +61 1300 468 289 Website: www.ausderm.com E-Mail: info@ausderm.com

AUSTRIA

Intramed Tel: +43 (1) 876 0101 Website: www.intramed.at E-Mail: office@intramed.at

SWITZERLAND

BKS-CONSULT Tel: +49 (0) 15204477306 Website: www.bks-consult.com E-Mail: info@bks-consult.com

GREAT BRITAIN

Globe AMT Tel: +44 1372 471 100 Website: www.globeamt.com E-mail: info@globeamt.com

BELGIUM

Dermat Medical Supplies Tel: +32 (0) 16/40 05 45 Website: www.dermat.be E-mail: info@dermat.be

NORDIC

Tobias Bergenblad
Global Sales Director (based in Sweden)
Email: tobias.bergenblad@scibase.com
Tel: +46 732 06 98 06

UNITED STATES

Email: us-sales@scibase.com   For a selection of clinics offering Nevisense, click here

UPCOMING LAUNCHES

This page will be continually updated with market specific details as Nevisense is launched in each respective market.

WHY NEVISENSE?

Unique diagnostic information

AVAILABLE MATERIALS

Download materials

FIND CLINICS

Selection of the growing list of clinics offering Nevisense

CLINICAL STUDIES

The largest prospective pivotal study in melanoma detection